Dr. Reddy's Laboratories reaches its June 3 earnings release with the same structural divide that has defined this entire preview cycle — short sellers entrenched near cycle highs, options traders resolutely unbothered.
The short side has barely moved since yesterday's article. Shares short edged up 0.7% on June 1 to approximately 19.7 million, a fractional tick back toward the 19.9 million cycle peak after the brief dip on May 29. The one-month build remains steep at 45%. The ORTEX short score has stabilised at 57.0, just off the 57.3 series high, and well above the mid-50s level that characterised early May. Availability has nudged up to 60.9% from 59.3% in yesterday's preview — still tight by the stock's own standards, but a genuine distance from the 31–33% cycle lows of the week of May 18–22. Cost to borrow has crept back up to 0.77%, reversing the brief easing to 0.70% seen on Friday. The lending market's message remains consistent: elevated short demand, a borrow rate running above its recent range, and a pool that is less congested than it was but still meaningfully tighter than it was a month ago.
Options traders have not shifted their view by a single basis point. The put/call ratio held at 0.15 on June 2 — the same 0.14–0.15 range that has anchored options flow since mid-May, and less than half the 20-day average of 0.41. That reading is close to the 52-week low of 0.009 on a historical basis, signalling that options market participants remain firmly positioned for upside rather than downside protection. The divergence between the two camps is now the most established fact in this stock's pre-earnings setup.
The stock itself has drifted lower through this cycle. RDY closed at $13.03 on June 2, down 1.7% on the day, 5.2% over the week, and 5% over the past month. The price action has run against the options-market consensus while broadly confirming the short sellers' directional bet. Analyst data is too stale to be actionable here — the most recent meaningful move, an HSBC upgrade to Buy with a $16.90 target reported in June 2025, is the most current reference available, though it predates this price decline and carries limited weight against current conditions.
The June 3 print is the first moment where the two sides of this unusually persistent divide will be forced to reconcile — with the short book's conviction and the options market's bullish lean both facing the same data at the same time.
See the live data behind this article on ORTEX.
Open RDY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
